Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 1, 2010, Pages 24-33

  Brito, Rossana Coimbra ^a   Mello, F C Q ^b   Andrade, M K ^b,c   Oliveira, H ^d   Costa, W ^a   Matos, H J ^e   Lourenco M C ^f   Rolla, V C ^f   Fonseca, L ^b   Ruffino Netto, A ^g   Kritski, A L ^b  

^a Secretaria Municipal de Saude e Defesa Civil do Rio de Janeiro   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Hospital Raphael de Paula Souza   (Brazil)

^d Hospital Estadual Santa Maria   (Brazil)

^e HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

^f Funda??o Oswaldo Cruz   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug resistance; Epidemiology; Hospitals; M. Tuberculosis; MDR TB

Indexed keywords

ADULT; ARTICLE; BACTERIAL STRAIN; BRAZIL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG RESISTANT TUBERCULOSIS; DYSPNEA; FEMALE; HEALTH SURVEY; HOSPITAL; HOSPITAL INFECTION; HUMAN; MALE; MEDICAL INFORMATICS; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BRAZIL; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; SEX FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 76149104936     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basu S, Andrews J R, Poolman E M, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 2007; 370: 1500-1507.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. 4th global report. The WHO/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. WHO/ HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
3. Beck-Sagué C, Dooley S W, Hutton M D, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992; 268: 1280-1286.
4. Busillo C P, Lessnau K D, Sanjana V, et al. Multidrug-resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest 1992; 102: 797-801.
5. McGowan J E Jr, Blumberg H M. Community as a source of infection: inner-city tuberculosis in the USA. J Hosp Infect 1995; 30 (Suppl 1): S282-S295.
6. Breathnach A S, de Ruiter A, Holdsworth G M, et al. An outbreak of multidrug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998; 39: 111-117.
7. Herrera D, Cano R, Godoy P, et al. Multidrug-resistant tuberculosis outbreak on a HIV ward - Madrid, Spain, 1991-1995. MMWR 1996; 45: 330-333.
8. Miralles Martín P, Moreno Guillén S, Parras Vázquez F, et al. Drug-resistant tuberculosis at a general hospital. Rev Clin Esp 1996; 196: 21-23.
9. Robert J, Trystram D, Truffot-Pernot C, Cambau E, Jarlier V, Grosset J. Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective. lnt J Tuberc Lung Dis 2000; 4: 504-512.
10. Mendoza M T, Gonzaga A J, Roa C, et al. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Phillipines. Int J Tuberc Lung Dis 1997; 1: 59-63.
11. Ignatova A, Dubiley S, Stepanshina V, Shemyakin I. Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Medical Microbiol 2006; 55: 1413-1418.
12. World Health Organization. WHO report 2006. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/ TB/2006.362. Geneva, Switzerland: WHO, 2006.
13. Ministério da Saúde, Brasil. Tuberculose: casos confirmados notificados no Sistema de Informação de Agravos de Notificação (Sinan). Brasilia, Brazil: Ministério da Saúde, 2004. http:// dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinan/ tuberculose/ bases/tubercbr.def Accessed January 2008. [Portuguese]
14. Fandinho F, Kritski A, Hofer C, et al. Drug resistance patterns among hospitalized tuberculous patients in Rio de Janeiro, Brazil, 1993-1994. Mem Inst Oswaldo Cruz 1999; 94: 543-547.
15. Brito R C, Gounder C, Lima D B, et al. Resistência aos medicamentos anti-tuberculose de cepas de Mycobacterium tuberculosis isoladas de pacientes atendidos em hospital geral de referência para tratamento de AIDS no Rio de Janeiro. J Bras Pneumol 2004; 30: 335-342. [Portuguese]
16. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of new alcoholism screening instrument. Am J Psychiatry 1974; 131: 1121-1123.
17. Akhtar M, Bretzel G, Boulahbal F, et al. Sputum examination for tuberculosis for direct microscopy in low-income countries. In: Management of tuberculosis. A guide for low-income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000.
18. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 14.
19. Aziz M A, Laszlo A, Raviglione M, Rieder H, Espinal M, Wright A. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. Geneva, Switzerland: WHO, 2003.
20. Barros A J, Hirakata V N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21.
21. Cuzick J. A Wilcoxon-type for test for trend. Stat Med 1985; 4: 87-89.
22. Braga J U, Barreto A M W, Hijjar M A. Inquérito epidemiológico da resistência às drogas usadas no tratamento da tuberculose no Brasil 1995-97, IERDTB. Parte III: Principals resultados. Bol Pneumol Sanit 2003; 11: 6. [Portuguese]
23. Matos E D, Lemos A C, Bittencourt C, et al. Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia. Braz J Infect Dis 2007; 11: 331-338.
24. Harrow E M, Rangel J M, Arriega M, et al. Epidemiology and clinical consequences of drug-resistant tuberculosis in Guatemalan Hospital. Chest 1998; 113: 1452-1458.
25. Lin J, Sattar A N, Puckree T. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. lnt J Tuberc Lung Dis 2004; 8: 568-573.
26. Yang Z H, Rendon A, Flores A, et al. A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico. lnt J Tuberc Lung Dis 2001; 5: 313-320.
27. Mendoza M T, Gonzaga A J, Roa C, et al. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines, lnt J Tuberc Lung Dis 1997; 1: 59-63.
28. McGowan J E Jr. Nosocomial tuberculosis: new progress in control and prevention. Clin Infec Dis 1995; 21: 489-505.
29. Gomes C, Rovaris D B, Severino J L, Gruner M F. Perfil de resistência de 'M. tuberculosis' isolados de pacientes portadores do HIV/AIDS atendidos em um hospital de referência. J Pneumologie 2000; 26: 25-29. [Spanish]
30. Enarson D A. Limitations of drug resistance surveillance. Conference on Global Lung Health and the 1997 Annual Meeting of the International Union Against Tuberculosis and Lung Disease, Paris, France. lnt J Tuberc Lung Dis 1997; 1 (Suppl 1): S18 (abstract).
31. Laszlo A, Urbanczik R, Bretzel G, Rüsch-Gerdes S, Feldmann K. Ethambutol sensitivity test. Int J Tuberc Lung Dis 2003; 7: 603-605.
32. Canetti G. The J. Burns Amberson Lecture: present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 1965; 92: 687-703.
33. Yew W W, Chau C H. Drug-resistant tuberculosis in the 1990s. Eur Respir J 1995; 8: 1184-1192.
34. Sharma S K, Turaga K K, Balamurugan A, et al. Clinical and genetic risk factors for the development of multidrug-resistant tuberculosis in non-HIV infected patients at a tertiary care centre in India: a case-control study. Infect Genet Evol 2003; 3: 183-188.
35. Harrow E M, Rangel J M, Arriega J M, et al. Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital. Chest 1998; 113: 1452-1458.
36. Dam T, Isa M, Bose M. Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates - a retrospective study from a chest-disease institute in India. J Med Microbiol 2005; 54: 269-271.
37. Wells C D, Cegielski J P, Nelson L J, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 (Suppl 1): S86-S107.